Boston Scientific Corporation (BSX)
USD 88.03
(-2.65%)
USD 88.03
(-2.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 9.89 Billion USD | 14.01% |
| 2022 | 8.67 Billion USD | 6.78% |
| 2021 | 8.12 Billion USD | 26.94% |
| 2020 | 6.4 Billion USD | -15.24% |
| 2019 | 7.55 Billion USD | 8.85% |
| 2018 | 6.94 Billion USD | 8.66% |
| 2017 | 6.38 Billion USD | 8.57% |
| 2016 | 5.88 Billion USD | 12.4% |
| 2015 | 5.23 Billion USD | 3.46% |
| 2014 | 5.05 Billion USD | 4.76% |
| 2013 | 4.82 Billion USD | 1.73% |
| 2012 | 4.74 Billion USD | -4.35% |
| 2011 | 4.96 Billion USD | -4.69% |
| 2010 | 5.2 Billion USD | -7.22% |
| 2009 | 5.61 Billion USD | 0.56% |
| 2008 | 5.58 Billion USD | -7.22% |
| 2007 | 6.01 Billion USD | 7.14% |
| 2006 | 5.61 Billion USD | 14.64% |
| 2005 | 4.89 Billion USD | 13.04% |
| 2004 | 4.33 Billion USD | 72.25% |
| 2003 | 2.51 Billion USD | 22.74% |
| 2002 | 2.04 Billion USD | 16.82% |
| 2001 | 1.75 Billion USD | -8.74% |
| 2000 | 1.92 Billion USD | -1.03% |
| 1999 | 1.94 Billion USD | 23.33% |
| 1998 | 1.57 Billion USD | 11.79% |
| 1997 | 1.4 Billion USD | 25.5% |
| 1996 | 1.12 Billion USD | 35.23% |
| 1995 | 830 Million USD | 180.59% |
| 1994 | 295.8 Million USD | 20.15% |
| 1993 | 246.2 Million USD | 21.1% |
| 1992 | 203.3 Million USD | 34.1% |
| 1991 | 151.6 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.64 Billion USD | 2.68% |
| 2024 Q3 | 2.89 Billion USD | 12.07% |
| 2024 Q2 | 2.58 Billion USD | -2.34% |
| 2023 Q2 | 2.52 Billion USD | 7.66% |
| 2023 Q4 | 2.57 Billion USD | 6.75% |
| 2023 Q1 | 2.34 Billion USD | 5.91% |
| 2023 Q3 | 2.41 Billion USD | -4.51% |
| 2023 FY | 9.89 Billion USD | 14.01% |
| 2022 Q4 | 2.21 Billion USD | 1.74% |
| 2022 FY | 8.67 Billion USD | 6.78% |
| 2022 Q3 | 2.18 Billion USD | -1.89% |
| 2022 Q1 | 2.05 Billion USD | -4.01% |
| 2022 Q2 | 2.22 Billion USD | 7.92% |
| 2021 Q2 | 2.12 Billion USD | 14.84% |
| 2021 Q1 | 1.84 Billion USD | 8.97% |
| 2021 Q4 | 2.14 Billion USD | 6.29% |
| 2021 Q3 | 2.01 Billion USD | -4.81% |
| 2021 FY | 8.12 Billion USD | 26.94% |
| 2020 FY | 6.4 Billion USD | -15.24% |
| 2020 Q1 | 1.72 Billion USD | -15.32% |
| 2020 Q2 | 1.2 Billion USD | -30.2% |
| 2020 Q3 | 1.77 Billion USD | 47.67% |
| 2020 Q4 | 1.69 Billion USD | -4.72% |
| 2019 Q3 | 1.91 Billion USD | 3.18% |
| 2019 FY | 7.55 Billion USD | 8.85% |
| 2019 Q4 | 2.03 Billion USD | 6.37% |
| 2019 Q2 | 1.85 Billion USD | 6.24% |
| 2019 Q1 | 1.74 Billion USD | -3.69% |
| 2018 FY | 6.94 Billion USD | 8.66% |
| 2018 Q3 | 1.7 Billion USD | -1.73% |
| 2018 Q2 | 1.73 Billion USD | 2.66% |
| 2018 Q1 | 1.68 Billion USD | -1.63% |
| 2018 Q4 | 1.81 Billion USD | 6.46% |
| 2017 Q2 | 1.6 Billion USD | 7.7% |
| 2017 FY | 6.38 Billion USD | 8.57% |
| 2017 Q3 | 1.56 Billion USD | -2.43% |
| 2017 Q4 | 1.71 Billion USD | 9.43% |
| 2017 Q1 | 1.49 Billion USD | -3.8% |
| 2016 Q2 | 1.46 Billion USD | 6.92% |
| 2016 Q1 | 1.37 Billion USD | -1.15% |
| 2016 FY | 5.88 Billion USD | 12.4% |
| 2016 Q3 | 1.49 Billion USD | 1.64% |
| 2016 Q4 | 1.55 Billion USD | 4.09% |
| 2015 Q1 | 1.23 Billion USD | -5.53% |
| 2015 Q2 | 1.28 Billion USD | 4.39% |
| 2015 Q3 | 1.33 Billion USD | 3.66% |
| 2015 Q4 | 1.38 Billion USD | 4.2% |
| 2015 FY | 5.23 Billion USD | 3.46% |
| 2014 FY | 5.05 Billion USD | 4.76% |
| 2014 Q4 | 1.3 Billion USD | 2.2% |
| 2014 Q3 | 1.27 Billion USD | -0.78% |
| 2014 Q2 | 1.28 Billion USD | 7.35% |
| 2014 Q1 | 1.19 Billion USD | -4.92% |
| 2013 Q4 | 1.25 Billion USD | 5.18% |
| 2013 Q1 | 1.14 Billion USD | -5.62% |
| 2013 Q2 | 1.23 Billion USD | 7.88% |
| 2013 FY | 4.82 Billion USD | 1.73% |
| 2013 Q3 | 1.19 Billion USD | -2.84% |
| 2012 Q2 | 1.25 Billion USD | 1.21% |
| 2012 Q1 | 1.23 Billion USD | 3.96% |
| 2012 FY | 4.74 Billion USD | -4.35% |
| 2012 Q4 | 1.21 Billion USD | 2.8% |
| 2012 Q3 | 1.17 Billion USD | -5.84% |
| 2011 FY | 4.96 Billion USD | -4.69% |
| 2011 Q1 | 1.29 Billion USD | -3.58% |
| 2011 Q2 | 1.28 Billion USD | -0.54% |
| 2011 Q3 | 1.19 Billion USD | -7.23% |
| 2011 Q4 | 1.18 Billion USD | -0.5% |
| 2010 Q3 | 1.29 Billion USD | 1.49% |
| 2010 Q1 | 1.29 Billion USD | -5.33% |
| 2010 Q2 | 1.27 Billion USD | -1.77% |
| 2010 Q4 | 1.34 Billion USD | 3.79% |
| 2010 FY | 5.2 Billion USD | -7.22% |
| 2009 Q1 | 1.4 Billion USD | 2.26% |
| 2009 Q4 | 1.37 Billion USD | -1.86% |
| 2009 Q3 | 1.39 Billion USD | -3.32% |
| 2009 Q2 | 1.44 Billion USD | 2.92% |
| 2009 FY | 5.61 Billion USD | 0.56% |
| 2008 Q4 | 1.37 Billion USD | 3.7% |
| 2008 Q3 | 1.32 Billion USD | -6.83% |
| 2008 Q2 | 1.42 Billion USD | -3.14% |
| 2008 Q1 | 1.46 Billion USD | -3.36% |
| 2008 FY | 5.58 Billion USD | -7.22% |
| 2007 FY | 6.01 Billion USD | 7.14% |
| 2007 Q4 | 1.51 Billion USD | 2.99% |
| 2007 Q3 | 1.47 Billion USD | -2.32% |
| 2007 Q2 | 1.5 Billion USD | -0.66% |
| 2007 Q1 | 1.51 Billion USD | -1.36% |
| 2006 Q4 | 1.53 Billion USD | 10.24% |
| 2006 Q3 | 1.39 Billion USD | -2.58% |
| 2006 Q2 | 1.43 Billion USD | 15.01% |
| 2006 Q1 | 1.24 Billion USD | 4.01% |
| 2006 FY | 5.61 Billion USD | 14.64% |
| 2005 Q4 | 1.19 Billion USD | 2.57% |
| 2005 Q3 | 1.16 Billion USD | -7.3% |
| 2005 Q2 | 1.26 Billion USD | -0.87% |
| 2005 FY | 4.89 Billion USD | 13.04% |
| 2005 Q1 | 1.27 Billion USD | -0.08% |
| 2004 Q2 | 1.09 Billion USD | 38.86% |
| 2004 Q4 | 1.27 Billion USD | 8.44% |
| 2004 FY | 4.33 Billion USD | 72.25% |
| 2004 Q1 | 790 Million USD | 15.84% |
| 2004 Q3 | 1.17 Billion USD | 6.93% |
| 2003 Q4 | 682 Million USD | 7.74% |
| 2003 Q2 | 619 Million USD | 6.54% |
| 2003 Q1 | 581 Million USD | -1.02% |
| 2003 FY | 2.51 Billion USD | 22.74% |
| 2003 Q3 | 633 Million USD | 2.26% |
| 2002 FY | 2.04 Billion USD | 16.82% |
| 2002 Q4 | 587 Million USD | 14.87% |
| 2002 Q3 | 511 Million USD | 5.8% |
| 2002 Q2 | 483 Million USD | 3.21% |
| 2002 Q1 | 468 Million USD | 1.3% |
| 2001 Q2 | 404 Million USD | -6.48% |
| 2001 Q4 | 462 Million USD | 1.32% |
| 2001 FY | 1.75 Billion USD | -8.74% |
| 2001 Q1 | 432 Million USD | -17.87% |
| 2001 Q3 | 456 Million USD | 12.87% |
| 2000 Q3 | 452 Million USD | -5.44% |
| 2000 Q1 | 466 Million USD | -17.52% |
| 2000 Q2 | 478 Million USD | 2.58% |
| 2000 FY | 1.92 Billion USD | -1.03% |
| 2000 Q4 | 526 Million USD | 16.37% |
| 1999 Q1 | 478 Million USD | -7.22% |
| 1999 Q4 | 565 Million USD | 38.48% |
| 1999 Q3 | 408 Million USD | -16.9% |
| 1999 Q2 | 491 Million USD | 2.72% |
| 1999 FY | 1.94 Billion USD | 23.33% |
| 1998 FY | 1.57 Billion USD | 11.79% |
| 1998 Q1 | 330 Million USD | -21.03% |
| 1998 Q2 | 354.5 Million USD | 7.42% |
| 1998 Q3 | 374.9 Million USD | 5.75% |
| 1998 Q4 | 515.2 Million USD | 37.42% |
| 1997 Q4 | 417.9 Million USD | 23.31% |
| 1997 FY | 1.4 Billion USD | 25.5% |
| 1997 Q1 | 286 Million USD | -19.23% |
| 1997 Q2 | 342.2 Million USD | 19.65% |
| 1997 Q3 | 338.9 Million USD | -0.96% |
| 1996 Q1 | 236.8 Million USD | -32.42% |
| 1996 Q4 | 354.1 Million USD | 31.54% |
| 1996 Q3 | 269.2 Million USD | 2.63% |
| 1996 Q2 | 262.3 Million USD | 10.77% |
| 1996 FY | 1.12 Billion USD | 35.23% |
| 1995 Q3 | 167.2 Million USD | 3.79% |
| 1995 Q4 | 350.4 Million USD | 109.57% |
| 1995 FY | 830 Million USD | 180.59% |
| 1995 Q1 | 151.3 Million USD | 73.71% |
| 1995 Q2 | 161.1 Million USD | 6.48% |
| 1994 Q4 | 87.1 Million USD | 22.68% |
| 1994 Q2 | 69.9 Million USD | 2.95% |
| 1994 Q1 | 67.9 Million USD | 3.03% |
| 1994 Q3 | 71 Million USD | 1.57% |
| 1994 FY | 295.8 Million USD | 20.15% |
| 1993 Q1 | 56.7 Million USD | 5.39% |
| 1993 Q2 | 61.5 Million USD | 8.47% |
| 1993 Q3 | 62 Million USD | 0.81% |
| 1993 Q4 | 65.9 Million USD | 6.29% |
| 1993 FY | 246.2 Million USD | 21.1% |
| 1992 FY | 203.3 Million USD | 34.1% |
| 1992 Q4 | 53.8 Million USD | 0.75% |
| 1992 Q3 | 53.4 Million USD | 8.32% |
| 1992 Q2 | 49.3 Million USD | 5.12% |
| 1992 Q1 | 46.9 Million USD | -26.49% |
| 1991 Q1 | 50.5 Million USD | 0.0% |
| 1991 Q4 | 63.8 Million USD | 6.51% |
| 1991 Q3 | 59.9 Million USD | 7.16% |
| 1991 FY | 151.6 Million USD | 0.0% |
| 1991 Q2 | 55.9 Million USD | 10.69% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 55.295% |
| Allurion Technologies Inc. | 41.49 Million USD | -23745.097% |
| Artivion, Inc. | 229.17 Million USD | -4217.642% |
| Avanos Medical, Inc. | 379.7 Million USD | -2506.005% |
| Butterfly Network, Inc. | 16.85 Million USD | -58603.132% |
| Butterfly Network, Inc. | 16.85 Million USD | -58603.132% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | -591.307% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -605469.155% |
| CONMED Corporation | 643.06 Million USD | -1438.72% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | -113.946% |
| Paragon 28, Inc. | 172.79 Million USD | -5626.571% |
| Glaukos Corporation | 239.13 Million USD | -4037.813% |
| Globus Medical, Inc. | 1.02 Billion USD | -869.811% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | -1773.262% |
| Integer Holdings Corporation | 418.28 Million USD | -2265.589% |
| Medtronic plc | 19.45 Billion USD | 49.134% |
| Nevro Corp. | 290.06 Million USD | -3311.363% |
| Owlet, Inc. | 22.58 Million USD | -43708.385% |
| Penumbra, Inc. | 682.64 Million USD | -1349.513% |
| Vicarious Surgical Inc. | -1.85 Million USD | 533810.895% |
| Smith & Nephew plc | 3.7 Billion USD | -167.36% |
| Sonendo, Inc. | 10.72 Million USD | -92186.887% |
| STERIS plc | 2.23 Billion USD | -342.928% |
| Stryker Corporation | 13.05 Billion USD | 24.223% |
| Vapotherm, Inc. | 28.28 Million USD | -34885.68% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | -86.332% |